SEC Comment Letter for CLOROX (CLX) — May 4, 2022
CLOROX CO /DE/ (CLX) (CIK 0000021076)
Date: May 4, 2022 · CIK: 0000021076 · Accession: 0000000000-22-004876
AI Filing Summary & Sentiment
File numbers found in text: 001-07151
Letter
United States securities and exchange commission logo May 4, 2022 Kevin Jacobsen Chief Financial Officer CLOROX CO /DE/ 1221 Broadway Oakland, California 94612 Re:CLOROX CO /DE/ Form 10-K for the Year Ended June 30, 2021 Form 10-Q for the Period Ended December 31, 2021 Form 8-K Filed February 3, 2022 File No. 001-07151 Dear Mr. Jacobsen: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
May 4, 2022
Kevin Jacobsen
Chief Financial Officer
CLOROX CO /DE/
1221 Broadway
Oakland, California 94612
Re:CLOROX CO /DE/
Form 10-K for the Year Ended June 30, 2021
Form 10-Q for the Period Ended December 31, 2021
Form 8-K Filed February 3, 2022
File No. 001-07151
Dear Mr. Jacobsen:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences